Evidence map›Paper›PMID 35242230›Full record

ArticleEcancermedicalscience2022

Symptom prevalence and burden, and the risk of depression among patients with advanced cancer attending two South African oncology units.

Lindsay Farrant, Richard Harding, David Anderson, Linda Greeff, Reshma Kassanjee, R Krause, Zainab Mohamed, Jeannette Parkes, Liz Gwyther

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lindsay FarrantDivision of Interdisciplinary Palliative Care and Medicine, Department Public Health and Family Medicine, Faculty of Health Science, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa.
Richard HardingCicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, Bessemer Road, London SE5 9PJ, UK.
David AndersonRadiation Oncology, Dunedin Hospital, Southern DHB, 201 Great King Street, Dunedin 9016, New Zealand.
Linda GreeffSocial Worker in Private Practice, Andrag Street, Welgemoed 7530, Cape Town, South Africa.
Reshma KassanjeeCentre for Infectious Disease Epidemiology and Research (CIDER), Department Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa.
R KrauseDivision of Interdisciplinary Palliative Care and Medicine, Department Public Health and Family Medicine, Faculty of Health Science, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa.
Zainab MohamedDivision of Radiation Oncology, Department of Radiation Medicine, Faculty of Health Science, University of Cape Town, L-Block D-Floor, Room D-8, Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa.
Jeannette ParkesDivision of Radiation Oncology, Department of Radiation Medicine, Faculty of Health Science, University of Cape Town, L-Block D-Floor, Room D-8, Groote Schuur Hospital, Observatory 7925, Cape Town, South Africa.
Liz GwytherDivision of Interdisciplinary Palliative Care and Medicine, Department Public Health and Family Medicine, Faculty of Health Science, University of Cape Town, Anzio Road, Observatory 7925, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of cancer is predicted to increase globally by 47% between 2020 and 2040, largely in low and middle-income countries. The World Health Organisation and World Health Assembly recognise palliative care as an essential component of cancer care. The evidence of palliative care needs among South African oncology patients is sparse. This study aimed to describe the prevalence and burden of symptoms and the risk of depression amongst oncology patients with stage 3 or 4 cancer.

methodsDemographic and clinical data were collected and the Memorial Symptom Assessment Scale Short Form was used to measure the 7-day period prevalence of 28 physical and 4 psychological symptoms of patients receiving oncology care. The Centre for Epidemiological Studies Depression Scale was used to measure the risk of depression.

resultsA total of DISCUSSION: Pain and depression persist in advanced cancer care despite the advances in policy and clinical education. Health services research must now focus on how to enact this in routine practice.

Indexed as

cancerdepressionpainpalliative caresymptoms

Identifiers

PMID35242230
PMCPMC8831113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.